Course

Wound Care: Venous Leg Ulcers

Time limit: 180 days
0.75 credits

Sorry! The enrollment period is currently closed. Please check back soon.

Full course description

Chronic wounds are such a significant health problem worldwide that they are considered the “new global epidemic.”  These wounds are often initially managed with various focal treatments, commonly for weeks or months, until involving a specialist. Even then, practices are inconsistent among practitioners and clinics, and although numerous guidelines are available, they are also inconsistent, mainly due to the lack of high-level evidence. 

The program is delivered in video format with a visual PowerPoint presentation and case scenarios. The program is approximately one hour in duration. Participants must complete all assessments and videos within the course.

TARGET AUDIENCE
This activity has been designed to meet the educational needs of physicians, pharmacists, nurses, nurse practitioners, physician assistants, fellows, medical students, nursing students, health care administrators, and other health care professionals.

LEARNING OBJECTIVES
After participating in this activity, clinicians will be able to:1) Costs of leg ulcers on both patients and the healthcare system; 2) The pathophysiology of ulceration; 3) Diagnosis and important lab studies; 4) Treatment modalities that affect patient outcomes and 5) Benefits of a multidisciplinary approach.

 

  • Explain the costs of leg ulcers on both patients and the healthcare system
  • Explain the pathophysiology of the disease
  • Describe the diagnosis thought process and important lab studies 
  • Explain how appropriate treatment modalities for venous leg ulcers affect patient outcomes and
  • Describe the benefit(s) of a multidisciplinary approach in managing venous leg ulcer injuries

Estimated Time to Complete: 45 minutes

Providership and Support
This educational activity is jointly provided by Albert Einstein College of Medicine-Montefiore Medical Center and Kaplan Medical.

This activity is not supported by grants from ineligible companies.